Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
New England Journal of Medicine · 10.09.2026 · 395 (10) · 959-971
DOI: 10.1056/nejmoa2602678 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 10.09.2026. Verfasst von Fernando C Fervenza und 16 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic, Rochester, MN. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Glomerulonephritis, Membranous, Immunosuppressive Agents, Tacrolimus. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: F. Hoffmann-La Roche.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Mayo Clinic, Rochester, MN.
- Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Huashan Hospital, Fudan University, Shanghai, China.
- Federal University of São Paulo, São Paulo.
- University of Bari Aldo Moro, Bari, Italy.
- Medical University of Białystok, Białystok, Poland.
ORCID-Profile: Fernando C Fervenza
Förderung
- F. Hoffmann-La Roche
Zitieren
APA
Fervenza, F. C., Hou, F. F., Hao, C. M., Kirsztajn, G. M., Gesualdo, L., Hryszko, T., Pisani, A., Roccatello, D., Bomback, A. S., Rae, J., Barmaki, F., Berisha, E., Schindler, T., Omachi, T. A., Garg, J. P., Malvar, A., & MAJESTY Trial Investigators (2026). Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy. New England Journal of Medicine, 395(10), 959-971. https://doi.org/10.1056/nejmoa2602678
Vancouver
Fervenza FC, Hou FF, Hao CM, Kirsztajn GM, Gesualdo L, Hryszko T, et al. Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy. New England Journal of Medicine. 2026;395(10):959-971. doi:10.1056/nejmoa2602678
BibTeX
@article{Fervenza2026,
author = {Fervenza, Fernando C and Hou, Fan Fan and Hao, Chuan-Ming and Kirsztajn, Gianna M and Gesualdo, Loreto and Hryszko, Tomasz and Pisani, Antonio and Roccatello, Dario and Bomback, Andrew S and Rae, Julie and Barmaki, Farima and Berisha, Eriola and Schindler, Thomas and Omachi, Theodore A and Garg, Jay P and Malvar, Ana and MAJESTY Trial Investigators, MAJESTY Trial Investigators},
title = {Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy},
journal = {New England Journal of Medicine},
year = {2026},
volume = {395},
number = {10},
pages = {959--971},
doi = {10.1056/nejmoa2602678}
}
EUVIMED